12-42472417-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_153026.3(PRICKLE1):c.100G>A(p.Ala34Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A34V) has been classified as Uncertain significance.
Frequency
Consequence
NM_153026.3 missense
Scores
Clinical Significance
Conservation
Publications
- epilepsy, progressive myoclonic, 1BInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Unverricht-Lundborg syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- progressive myoclonus epilepsyInheritance: AR Classification: LIMITED Submitted by: ClinGen
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PRICKLE1 | NM_153026.3 | c.100G>A | p.Ala34Thr | missense_variant | Exon 2 of 8 | ENST00000345127.9 | NP_694571.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251222 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461860Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74314 show subpopulations
ClinVar
Submissions by phenotype
Self-limited epilepsy with centrotemporal spikes Pathogenic:1
CAADphred>15 -
Epilepsy, progressive myoclonic, 1B Uncertain:1
This sequence change replaces alanine with threonine at codon 34 of the PRICKLE1 protein (p.Ala34Thr). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and threonine. This variant is present in population databases (rs781255236, ExAC 0.01%). This missense change has been observed in individual(s) with clinical features of PRICKLE1-related conditions (PMID: 29358611). ClinVar contains an entry for this variant (Variation ID: 418596). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
A variant of uncertain significance has been identified in the PRICKLE1 gene. The A34T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The A34T variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The A34T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals; however, Threonine is observed at this position in evolution. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at